Tumor-targeted interferon-α gene therapy for glioblastoma: a phase 1 trial
2d ago· 1 min readNews
Source
Phase 1/2a trial reports Temferon’s potential in GBM: 24 patients received stem cell transplants delivering INF-α2 to boost local antitumor immunity; interim results promising. PMID:42225991, Nat Med 2026, @NatureMedicine #Medsky #Pharmsky #RNA #ASHG 🧪
You might also wanna read
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Nature Communications

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
cell.com·9d ago
Clinical trial explores high-dose vitamin B3 as potential treatment for glioblastoma brain cancer
A clinical trial is exploring whether high doses of vitamin B3 (niacin) could help patients with glioblastoma, an aggressive and deadly brai
sciencedaily.com·11d ago
First Successful In-Utero Stem Cell Therapy for Spina Bifida Shows Safety in Phase 1 Trial
UC Davis Health researchers have successfully performed the world's first in-utero stem cell therapy for spina bifida repair, combining feta
Life Biosciences Conducts First Gene Therapy Trial to Reverse Cellular Aging in Patient with Glaucoma
Life Biosciences, a Boston-based biotech startup, has conducted the world's first gene therapy on a living patient aimed at reversing cellul
Gemma-Based AI Model Identifies Potential Cancer Therapy Pathway Through Conditional Immune Amplification
Researchers used a new 27 billion parameter foundation model called C2S-Scale 27B, built on Google's Gemma family of open models, to discove

Comments
Sign in to join the conversation.
No comments yet. Be the first.